Gray platelet syndrome (GPS) is an autosomal recessive bleeding disorder that is characterized by large platelets that lack a-granules. Here we show that mutations in NBEAL2 (neurobeachin-like 2), which encodes a BEACH/ARM/WD40 domain protein, cause GPS and that megakaryocytes and platelets from individuals with GPS express a unique combination of NBEAL2 transcripts. Proteomic analysis of sucrose-gradient subcellular fractions of platelets indicated that NBEAL2 localizes to the dense tubular system (endoplasmic reticulum) in platelets.
Clinical manifestations of GPS are usually mild to moderate and rarely severe 6 . GPS is also associated with myelofibrosis ( Fig. 1e,f) and splenomegaly as a consequence of myelofibrosis [5] [6] [7] . The basis of the myelofibrosis remains unknown, but constitutive release of platelet-derived growth factor and other profibrotic substances from megakaryocytes into the bone marrow may be involved 5 .
Some platelet α-granule constituents are passively (for example, immunoglobulins and albumin) or actively (for example, fibrinogen) taken up from the plasma by receptor-mediated endocytosis; others are synthesized in megakaryocytes (for example, platelet factor 4 and β-thromboglobulin) and trafficked to the organelle 3 . In individuals with GPS, amounts of proteins that are synthesized in megakaryocytes are markedly reduced, whereas endocytosed α-granule constituents are less affected 3 . This suggests that megakaryocytes in indivduals with GPS fail to pack their endogeneously synthesized secretory proteins into developing α-granules.
By genome-wide linkage analysis and homozygosity mapping of 25 individuals with GPS from 14 unrelated families, we previously mapped the GPS disease locus to a 9.4-megabase interval on chromosome 3p21.1-22.1 that includes 197 protein-coding genes 6 . Initial whole-exome and Sanger dideoxy sequencing revealed no mutations in any of these genes, but subsequent Sanger dideoxy sequencing of exons not previously covered did reveal mutations in a single gene. In fact, 15 unrelated individuals with GPS had mutations in NBEAL2 , including five missense, three nonsense, four frameshifting and three consensus splice-site mutations ( Table 1, Fig. 1g and Supplementary Figs. 1 and 2) . None of these variants was found in the 1000 Genomes Database (see URLs), which contained 629 genomes as of February 2011, or in 100 ethnically matched control individuals. The 14 affected individuals with identity by descent had homozygous mutations ( Table 1) , whereas those without identity by descent had compound heterozygous mutations.
All missense variants altered conserved amino acids and had high pathogenicity prediction scores (Supplementary Fig. 1p ). Splice donor site mutations c.1296+5G>A and c.5301+1G>A result in the use of cryptic intronic donor sites, as detected in blood mRNA, and c.5720+5G>A is predicted to obliterate a splice donor site (Supplementary Fig. 1) .
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Human NBEAL2 is predicted to produce 15 mRNA transcripts, of which 7 would be protein coding (Supplementary Fig. 3a) . We designed cDNA primers to differentially amplify all protein-encoding NBEAL2 transcripts (Supplementary Fig. 3 ) and tested RNA from a variety of human hematopoietic cells and other tissues. A unique combination of transcripts encoding Ensembl isoforms NBEAL2-001, NBEAL2-201/003, NBEAL2-203/004 and NBEAL2-202 was expressed in megakaryocytes and platelets (Supplementary Table 1 ).
Antibodies to NBEAL2 are not commercially available. To explore the subcellular localization of NBEAL2 protein, we performed proteomic analysis on sucrose-gradient subcellular fractions from normal platelets and identified two tryptic peptides from NBEAL2 by mass spectrometry (Fig. 1g and Supplementary Fig. 4 ). These peptide sequences, contained within NBEAL2 transcripts 001, 003 and 201, were found in platelet subcellular fraction 4, which contained small membrane structures on electron microscopic analysis 2 that probably originated from the dense tubular system. In fact, fraction 4 was enriched in markers for the dense tubular system and endoplasmic reticulum (data not shown).
The fibrotic nature of bone marrow in individuals with GPS prevented us from obtaining sufficient bone marrow for ex vivo expansion of megakaryocytes (the only cell type that expresses the GPS phenotype of defective α-granule biogenesis). Our previous microarray data in fibroblasts from individuals with GPS showed overexpression of fibronectin 11 , a protein essential for proplatelet formation in cultured megakaryocytes 12 and crucial for megakaryocyte-matrix interactions 13 . fig. 2 ) showed identity by descent. In GPS-12, only one heterozygous mutation was identified, and no tissue was available for NBEAL2 mRNA analysis. NA, not available.
b r i e f c o m m u n i c a t i o n s
Future studies of megakaryocytes from individuals with GPS might shed light on the pathogenesis of myelofibrosis in GPS. It is not known how the absence of NBEAL2 function in megakaryocytes results in defective α-granule biogenesis. However, NBEAL2 belongs to the family of proteins that contain ARM, BEACH (beige and Chediak-Higashi syndrome) and WD40 domains, highly conserved regions that are crucial for protein-protein interactions, membrane dynamics and vesicle trafficking 14 . Another such protein is CHS1, which is defective in Chediak-Higashi disease (CHD, MIM214500), a disorder of immunodeficiency, platelet dense-granule defects, partial albinism and enlarged lysosomes or lysosome-related organelles in hematopoietic cells and melanocytes 4, 15 . The precise cell-biological defects in GPS and CHD remain unknown, but both diseases involve large proteins and impaired formation and trafficking of intracellular vesicles. NBEAL2 is predicted to interact with WDFY3 (WD repeat and FYVE domain-containing 3), as well as DLL1 and jagged 1, which are involved in hematopoiesis, according to an analysis with Gene Network Central (see URLs). In addition, WDFY3 itself interacts with CHS1. DLL1 is the human homolog of the notch Delta ligand, and jagged 1 is the ligand for the receptor notch 1. These predicted protein-protein interactions are entirely based on computational predictions; future experiments will determine their accuracy. Understanding the function of NBEAL2 will probably lead to the discovery of new pathways of organelle formation and maturation.
URLs. 1000 Genomes Project Database, http://www.1000genomes.org/; http://www.sabiosciences.com/genenetwork/genenetworkcentral.php.
Accession codes. NBEAL2, Ensembl ENSG00000160796; NBEAL2-001 isoform, Ensembl ENST00000450053.
